arenavirus
envelop
negativesens
singlestrand
rna
ssrna
virus
famili
arenavirida
current
consist
four
genera
mammarenaviru
reptarenaviru
hartmaniviru
antennaviru
except
triseg
antennaviru
genu
arenaviru
genom
biseg
one
larg
l
segment
around
kb
one
small
segment
around
kb
segment
contain
two
open
read
frame
orf
encod
two
gene
product
opposit
orient
allow
viru
assum
ambisens
code
strategi
two
orf
separ
highli
structur
intergen
region
igr
function
termin
viral
rna
transcript
conserv
termini
region
genom
segment
form
panhandl
structur
mediat
viral
rna
replic
transcript
segment
encod
viral
glycoprotein
gp
precursor
posttransl
cleav
stabl
signal
peptid
ssp
matur
three
cleav
product
form
glycoprotein
complex
incorpor
virion
form
spike
surfac
virion
bind
host
receptor
mediat
cell
entri
segment
also
encod
nucleoprotein
np
abund
viral
protein
produc
infect
major
structur
compon
nucleocapsid
l
segment
encod
rnadepend
rna
polymeras
l
protein
small
zinc
finger
protein
z
act
arenaviru
matrix
protein
drive
assembl
bud
viru
particl
within
famili
arenavirida
human
pathogen
member
mammarenaviru
genu
mammarenavirus
separ
two
group
base
geographi
phylogeni
old
world
ow
arenavirus
new
world
nw
arenavirus
lassa
viru
lasv
endem
west
africa
therefor
classifi
ow
arenaviru
prototyp
lymphocyt
choriomening
viru
lcmv
also
classifi
ow
arenaviru
base
similar
phylogeni
meanwhil
nw
arenavirus
endem
south
america
divid
four
clade
clade
b
contain
pathogen
nw
arenavirus
includ
junv
machupo
virus
macv
caus
agent
argentin
hemorrhag
fever
ahf
bolivian
hemorrhag
fever
bhf
respect
notabl
clade
contain
prototyp
pichind
viru
nonpathogen
human
caus
hemorrhag
diseas
rodent
similar
lassa
fever
lf
human
mammarenaviru
except
tacarib
viru
rodentborn
virus
usual
infect
specif
rodent
speci
therefor
geograph
distribut
arenaviru
defin
rang
habitat
host
rodent
speci
mastomi
natalensi
reservoir
lasv
found
across
much
africa
though
lasv
infect
occur
natalensi
monophylogenet
group
west
africa
nw
arenavirus
likewis
primarili
infect
singl
speci
rodent
america
arenavirus
often
persist
infect
natur
host
without
overt
diseas
sign
shed
via
excreta
infect
anim
transmiss
pathogen
arenavirus
human
occur
larg
aerosol
exposur
rodent
excreta
consumpt
rodent
meat
infect
occur
rural
set
often
cyclic
outbreak
howev
nosocomi
transmiss
lasv
junv
macv
report
within
endem
area
ow
nw
arenavirus
respons
signific
human
diseas
among
highli
pathogen
arenavirus
lasv
preval
clinic
import
estim
infect
death
west
africa
year
lasv
infect
asymptomat
sever
lf
case
fatal
rate
rang
among
hospit
patient
pathogen
nw
arenavirus
junv
macv
case
fatal
rate
high
addit
sever
acut
diseas
high
mortal
rate
human
longterm
sequela
common
often
neglect
among
survivor
patient
recov
ahf
bhf
often
experi
protract
convalesc
period
hair
loss
neurolog
symptom
dizzi
headach
last
sever
month
acut
infect
neurolog
sequela
also
report
lf
case
recent
preval
impact
lasvinduc
hear
loss
becom
increasingli
recogn
signific
social
econom
burden
affect
area
approxim
lf
survivor
develop
unilater
bilater
suddenonset
sensorineur
deaf
may
perman
exact
mechan
behind
develop
longterm
sequela
infect
highli
pathogen
arenavirus
remain
determin
cellmedi
immun
may
involv
current
vaccin
treatment
limit
hemorrhag
fevercaus
arenavirus
world
health
organ
list
lf
blueprint
list
prioriti
diseas
urgent
need
acceler
research
develop
highli
pathogen
ow
nw
arenavirus
caus
sever
diseas
human
innat
immun
respons
remark
differ
figur
despit
high
uncheck
level
viremia
sever
lf
case
gener
character
profound
immunosuppress
includ
weak
delay
type
interferon
ifni
proinflammatori
cytokin
respons
particularli
earli
stage
ill
contrast
pathogen
nw
arenaviru
infect
stimul
robust
ifni
respons
patient
ahf
case
serum
level
report
peak
iuml
one
highest
circul
interferon
level
record
viral
diseas
elev
level
also
observ
serum
ahf
patient
high
ifni
cytokin
level
correl
sever
outcom
ahf
diseas
also
evid
ifn
respons
may
contribut
thrombocytopenia
ahf
patient
pathogen
ow
nw
arenaviru
infect
also
induc
differenti
adapt
immun
respons
could
link
profound
differ
innat
respons
figur
host
innat
immun
respons
act
directli
counteract
viru
infect
also
motiv
regul
virusspecif
adapt
immun
respons
provid
longterm
protect
dendrit
cell
dc
macrophag
present
viral
antigen
cell
essenti
compon
innat
immun
respons
adapt
immun
respons
cell
also
earli
target
arenaviru
infect
lasv
effici
infect
monocytederiv
dendrit
cell
modc
macrophag
without
stimul
ifn
cytokin
respons
consequ
lasvinfect
modc
macrophag
fail
activ
cell
explain
delay
cellular
immun
respons
nonpathogen
ow
mopeia
viru
mopv
genet
close
relat
lasv
use
control
studi
pathogenesi
lasv
contrast
lasv
mopv
infect
induc
strong
ifn
cytokin
respons
modc
macrophag
lead
cell
activ
host
myeloid
dendrit
cell
mdc
special
antigen
present
induct
cell
respons
recent
studi
identifi
lasv
mopv
infect
mdc
ex
vivo
abort
due
ifn
cytokin
respons
block
ifn
enabl
product
infect
lasv
mopv
mdc
interestingli
mdc
autolog
cell
cocultur
model
mdc
activ
ifn
respons
remark
reduc
delay
lasv
infect
mdc
activ
ifni
respons
mopv
infect
increas
prolong
consist
lasvinfect
mdc
activ
cell
mopvinfect
mdc
effici
activ
cell
mechan
underli
appar
neg
regul
mdc
activ
ifn
respons
cell
lasv
infect
remain
unknown
also
unclear
cell
type
eg
nk
cell
might
present
cocultur
contribut
phenotyp
plasmacytoid
dendrit
cell
pdc
import
ifn
produc
vivo
lasv
mopv
infect
pdc
abort
though
lasv
infect
produc
less
sustain
lower
level
ifni
respons
mopv
nevertheless
found
lf
survivor
develop
virusspecif
cell
respons
acut
stage
infect
associ
lasv
clearanc
recoveri
gener
believ
humor
respons
import
clearanc
lasv
even
lf
survivor
develop
neutral
antibodi
month
acut
infect
resolv
contrast
ahf
patient
develop
neutral
antibodi
junv
acut
phase
diseas
essenti
viru
clearanc
furthermor
ahf
bhf
success
treat
use
convalesc
immun
sera
survivor
research
use
anim
model
pathogen
arenaviru
infect
recapitul
mani
clinic
observ
nhp
infect
lasv
typic
develop
lymphopenia
though
surviv
correl
increas
number
cell
surviv
nhp
lasv
infect
also
correl
earli
ifni
respons
fatal
nhp
infect
character
lack
type
ifn
product
lf
chimer
mous
model
wildtyp
bone
marrow
cell
transplant
irradi
type
interferon
receptor
knockout
mice
develop
recent
reproduc
main
symptom
lf
model
cellmedi
immunopatholog
appar
play
essenti
role
lf
diseas
highlight
dual
activ
tcell
respons
lf
studi
requir
determin
whether
earli
tcell
respons
aid
lasv
clearanc
whether
late
dysregul
tcell
respons
may
actual
contribut
sever
lf
hand
junv
infect
elicit
robust
ifni
respons
nhp
guinea
pig
observ
lf
patient
neutral
antibodi
lasv
form
either
surviv
nhp
guinea
pig
acut
phase
infect
contrast
neutral
antibodi
develop
earli
infect
critic
clearanc
junv
infect
guinea
pig
macv
infect
also
induc
potent
ifn
respons
nhp
guinea
pig
addit
demonstr
human
case
ahf
immun
plasma
effect
treatment
ahf
nhp
data
demonstr
hemorrhag
fevercaus
ow
nw
arenavirus
trigger
vastli
differ
immun
respons
implic
viral
pathogenesi
well
develop
vaccin
therapeut
viral
rna
often
contain
uniqu
featur
group
doublestrand
rna
structur
distinguish
host
rna
addit
viralderiv
doublestrand
rna
dsrna
molecul
might
form
byproduct
viral
rna
replic
figur
host
pattern
recognit
receptor
prr
effici
recogn
pathogenassoci
molecular
pattern
pamp
danger
signal
viru
infect
initi
downstream
signal
cascad
ultim
result
antivir
respons
among
prr
tolllik
receptor
known
recogn
ssrna
endosom
role
pathogen
arenaviru
infect
determin
major
research
prr
recognit
arenavirus
focus
prr
primarili
recogn
dsrna
retino
acidinduc
gene
rigi
protein
kinas
r
pkr
figur
arenaviru
genom
contain
nonself
rna
pattern
might
act
pamp
end
genom
form
pppcontain
panhandl
structur
intergen
region
natur
form
hairpin
loop
facilit
transcript
termin
line
junvinduc
ifn
respons
recent
imag
studi
reveal
dsrna
accumul
junv
infect
dsrna
signal
coloc
prr
rigi
pkr
well
melanoma
differentiationassoci
protein
strongli
suggest
dsrna
recogn
activ
prr
arenaviru
infect
rigi
demonstr
mediat
ifn
respons
pathogen
nw
arenaviru
infect
pathogen
ow
lasv
seemingli
evolv
abil
evad
rigi
respons
rigi
primarili
recogn
triphosph
ssrna
dsrna
undergo
conform
shift
ubiquitin
interact
activ
mitochondri
antivir
signal
protein
mav
figur
mav
activ
lead
downstream
signal
cascad
induc
activ
nuclear
transloc
interferon
regulatori
factor
well
nuclear
factor
kappa
b
ultim
upregul
gene
express
ifn
proinflammatori
cytokin
studi
shown
transfect
lasv
rna
activ
promot
rigidepend
manner
express
upregul
context
lasv
infect
indic
lasv
effici
evad
inhibit
ifn
respons
context
viru
infect
contrast
ifn
interferonstimul
gene
isg
upregul
junv
macv
infect
knockdown
rigi
use
sirna
substanti
reduc
isg
product
junvinfect
cell
indic
ifn
pathway
activ
rigi
depend
manner
junv
infect
recent
screen
gene
upregul
nw
arenaviru
infect
identifi
elev
ifn
isg
gene
express
includ
rigi
nonpathogen
nw
tacarib
viru
tcrv
candid
vaccin
strain
junv
infect
junv
np
found
coloc
rigi
infect
cell
imag
studi
though
influenc
np
rigi
function
still
unknown
candid
strain
junv
also
shown
induc
nuclear
transloc
indic
rigimedi
ifn
respons
function
junv
infect
anoth
cytosol
rigilik
receptor
rlr
also
shown
play
role
arenaviru
infect
bind
preferenti
long
dsrna
ligand
activ
ifn
pathway
similarli
rigi
junv
infect
visual
coloc
dsrna
along
np
suggest
recogn
dsrna
junv
infect
unlik
rigi
requir
stimul
upon
transfect
lasv
rna
recent
studi
myeloid
dendrit
cell
reveal
nonpathogen
mopv
lasv
induc
upregul
gene
express
sinc
isg
upregul
like
mediat
ifn
respons
upregul
also
observ
nonpathogen
tcrv
infect
well
candid
infect
apart
rlr
dsrnaactiv
protein
kinas
r
pkr
also
becom
activ
follow
junv
macv
lasv
infect
figur
pkr
ubiquit
express
cell
transcript
induc
ifn
upon
dsrna
recognit
pkr
undergo
autophosphoryl
becom
enzymat
activ
pkr
phosphoryl
eukaryot
translat
initi
factor
lead
translat
shutoff
figur
lasv
infect
activ
pkr
prevent
pkr
activ
presenc
dsrna
analog
poli
c
impli
lasv
evad
pkr
detect
rather
directli
interf
kinas
activ
contrast
pkr
activ
junv
pathogen
romero
strain
macv
infect
concomit
phosphoryl
translat
inhibit
express
ifn
isg
eg
augment
pkrdefici
cell
compar
wildtyp
cell
junv
macv
infect
pathogen
romero
strain
junv
macv
replic
slightli
effici
wildtyp
cell
pkrdefici
cell
result
suggest
pathogen
nw
arenavirus
exploit
pkr
activ
facilit
viru
infect
attenu
isg
express
vaccin
candid
strain
junv
also
activ
pkr
interestingli
candid
junv
infect
neither
result
phosphoryl
translat
inhibit
unlik
pathogen
romero
strain
junv
knockout
pkr
affect
candid
junv
replic
candid
infect
block
poli
c
induc
phosphoryl
worth
note
np
interact
pkr
candid
infect
cell
whether
junv
np
affect
pkr
pathway
need
address
futur
studi
nonpathogen
tcrv
also
induc
pkr
activ
phosphoryl
knock
pkr
facilit
tcrv
infect
indic
tcrv
suscept
pkrmediat
antivir
respons
arenavir
np
identifi
ifn
antagonist
target
differ
step
ifn
pathway
figur
examin
crystal
structur
lasv
np
reveal
deddh
exonucleas
exon
motif
preferenti
target
dsrna
purifi
np
lasv
tcrv
mopv
picv
shown
degrad
dsrna
biochemistri
assay
exon
motif
highli
conserv
among
arenavirus
propos
degrad
viral
dsrna
produc
viral
replic
prevent
recognit
nonself
rna
sensor
rigi
otherwis
trigger
innat
immun
respons
figur
howev
dsrna
readili
detect
junvinfect
cell
coloc
prr
rigi
pkr
consist
robust
ifnpkr
respons
observ
junv
infect
cell
therefor
role
np
exon
context
viru
infect
remain
examin
futur
studi
possibl
np
exon
activ
regul
differ
among
arenavirus
also
possibl
highli
conserv
np
exon
may
addit
function
critic
arenavirus
addit
exon
activ
np
pathogen
arenaviru
demonstr
block
activ
howev
pathway
appear
complet
block
nw
arenaviru
infect
one
possibl
ifn
antagonist
activ
np
pathogen
nw
arenavirus
junv
macv
weaker
lasv
np
viru
infect
explain
signal
pathway
activ
junv
macv
lasv
infect
np
nonpathogen
tcrv
mopv
degrad
dsrna
biochemistri
assay
express
tcrv
np
inhibit
ifn
report
gene
express
similarli
lasv
np
henc
seem
nonpathogen
pathogen
arenavirus
sometim
similar
antiifn
activ
worth
note
data
base
assay
purifi
plasmidexpress
np
nevertheless
tcrv
mopv
infect
induc
ifn
respons
infect
kinet
level
np
express
well
distribut
np
differ
plasmidexpress
cell
addit
np
also
engag
viral
rna
replic
rnp
format
virion
format
therefor
interact
np
ifn
pathway
may
differ
infect
cell
compar
plasmidexpress
cell
may
reconcil
differ
sometim
observ
express
infect
studi
differ
interplay
pkr
also
observ
among
arenaviru
np
unlik
candid
junv
np
neither
lasv
lcmv
np
bind
pkr
coexpress
cell
coloc
pkr
nw
arenaviru
np
also
visual
candid
tcrv
infect
cell
though
research
need
np
arenavirus
interact
rigi
pkr
pathway
differenti
may
contribut
differ
innat
immun
respons
observ
clinic
case
recent
research
also
reveal
arenavir
np
inhibit
pactenhanc
rigimedi
ifn
respons
pact
cellular
protein
bind
directli
dsrna
rigi
figur
ebov
iav
merscov
n
demonstr
block
pact
enhanc
rigimedi
ifn
respons
disrupt
pact
rigi
interact
np
variou
arenavirus
lasv
junv
macv
tcrv
picv
inhibit
pactenhanc
rigimedi
ifn
report
gene
express
inhibit
block
pactrigi
bind
rather
depend
np
exonucleas
activ
lasv
picv
np
mutant
defect
exonucleas
activ
unabl
inhibit
pactpotenti
product
thu
arenaviru
np
specul
degrad
dsrna
therebi
prevent
pact
bind
dsrna
pact
known
activ
pkr
though
role
arenavir
np
pactmedi
pkr
activ
remain
unknown
recent
largescal
protein
interact
screen
reveal
ow
nw
arenaviru
np
interact
host
deadbox
atpdepend
rna
helicas
exhibit
provir
role
arenavirus
replic
lcmv
lasv
junv
substanti
impair
knockout
cell
two
differ
mechan
propos
provir
effect
earli
infect
assist
viral
rna
replic
support
reduc
arenaviru
minigenom
replic
knockout
cell
mutat
atpas
helicas
domain
also
lead
reduc
minigenom
replic
indic
domain
essenti
provir
function
late
infect
may
act
suppress
ifn
product
facilit
lcmv
infect
contrast
affect
transcript
junv
infect
addit
np
arenaviru
z
protein
also
implic
suppressor
host
innat
immun
respons
z
shown
directli
interact
rigi
prevent
associ
mav
thu
block
ifn
signal
figur
origin
differenti
role
z
protein
ow
nw
arenavirus
assum
z
protein
nw
arenavirus
seem
uniqu
capabl
inhibit
rigimedi
signal
howev
recent
research
reveal
z
protein
pathogen
arenavirus
nonpathogen
arenavirus
abl
inhibit
rigi
signal
inhibit
mediat
interact
ntermin
domain
z
protein
card
domain
rlr
disrupt
rlr
mav
interact
ifn
antagonist
activ
z
protein
found
promin
macrophag
rais
possibl
z
protein
might
inhibit
ifn
respons
mainli
macrophag
np
act
mainli
dc
work
need
studi
role
z
protein
modul
host
immun
respons
autophagi
pathway
import
compon
host
antivir
defens
function
degrad
pathogen
trigger
innat
adapt
immun
mani
virus
evolv
suppress
autophagi
pathway
other
hijack
assist
viral
replic
role
autophagi
arenaviru
infect
larg
unknown
recent
research
provid
evid
provir
role
autophagi
two
group
observ
virul
attenu
strain
junv
induc
autophagi
earli
infect
induct
autophagi
prior
infect
result
increas
np
express
ow
mopv
also
transient
induc
autophagi
first
two
day
infect
though
lasv
nevertheless
deplet
essenti
autophag
vesicl
protein
impair
mopv
lasv
junv
replic
indic
ow
nw
arenavirus
may
util
compon
autophagi
pathway
aid
replic
key
compon
autophagi
increas
evid
also
play
role
nonautophagi
process
includ
neg
regul
rigi
thu
futur
studi
requir
defin
directli
involv
arenaviru
replic
mechan
behind
autophagi
induct
arenaviru
infect
unclear
one
group
determin
unlik
replicationcompet
junv
uvinactiv
junv
induc
autophagi
hour
postexposur
howev
anoth
group
observ
autophagi
induct
hour
exposur
uvinactiv
junv
though
unclear
whether
virusdriven
autophagi
like
play
role
late
arenaviru
infect
deplet
reduc
extracellular
intracellular
lasv
mopv
rna
level
sever
viral
protein
demonstr
interact
directli
key
compon
autophagi
pathway
mopv
z
lesser
extent
lasv
z
interact
sequestosom
receptor
junv
np
also
visual
coloc
howev
biolog
signific
viral
protein
interact
compon
autophagi
remain
unknown
anoth
mean
pathogen
arenavirus
may
subvert
host
immun
respons
may
prevent
avoid
activ
natur
killer
nk
cell
nk
cell
activ
depend
mixtur
activ
inhibit
signal
present
apc
shown
lasvactiv
macrophag
abl
activ
nk
cell
activ
incomplet
ultim
suppress
viral
replic
npmediat
immunosuppress
like
play
role
prevent
nk
cell
activ
mutant
lack
np
exonucleas
function
abl
fulli
activ
nk
cell
cocultur
apc
furthermor
hypothes
lasv
may
util
nk
inhibitori
receptor
escap
detect
lasvactiv
nk
cell
abl
lyse
cell
lack
hla
express
lyse
lasvinfect
dc
constitut
express
hla
recent
studi
reveal
certain
lasv
epitop
bound
molecul
activ
inhibitori
nk
cell
receptor
thu
prevent
nk
cell
activ
patient
succumb
lf
like
carri
gene
survivor
specif
interact
lasv
bound
hla
molecul
varieti
inhibitori
nk
cell
receptor
may
explain
clinic
variabl
seen
lf
case
arenavirus
attenu
candid
junv
vaccin
approv
use
human
argentina
vaccin
elicit
strong
protect
neutral
antibodi
respons
vaccin
success
control
ahf
within
endem
region
chimer
macv
express
gpc
candid
junv
highli
attenu
mous
model
protect
anim
lethal
macv
challeng
protect
correl
high
titer
macvspecif
neutral
antibodi
challeng
sever
lasv
vaccin
candid
current
preclin
stage
promis
base
safeti
immunogen
efficaci
anim
model
lasvmopv
reassort
viru
contain
segment
lasv
l
segment
mopv
vaccin
platform
express
main
lasv
antigen
gpc
np
vaccin
efficaci
protect
nhp
guinea
pig
lasv
challeng
cellmedi
immun
meanwhil
neutral
antibodi
detect
level
recombin
vesicular
stomat
viru
vector
express
lasv
gpc
efficaci
protect
nhp
lethal
lasv
challeng
immun
low
level
neutral
antibodi
detect
vaccin
anim
meanwhil
tcell
respons
measur
one
four
anim
nevertheless
vaccin
nhp
surviv
challeng
develop
potent
humor
cellular
immun
respons
final
vaccin
nhp
vaccinia
viru
vector
express
lasv
confer
protect
lethal
lasv
challeng
antibodi
respons
low
survivor
protect
like
cellmedi
immun
vaccinia
viru
known
induc
cellular
immun
respons
predominantli
survivor
pathogen
arenaviru
infect
often
develop
postinfect
sequela
month
follow
acut
stage
ill
neurolog
symptom
common
nw
arenaviru
infect
correl
robust
viral
replic
neurolog
tissu
evidenc
high
viral
titer
brain
infect
anim
macv
antigen
also
preferenti
detect
within
neuron
interestingli
treatment
ahf
bhf
convalesc
serum
increas
likelihood
develop
longterm
neurolog
syndrom
whether
neurolog
damag
directli
caus
viru
infect
immunemedi
mechan
still
unknown
lasv
infect
accumul
evid
rais
possibl
neurolog
sequela
like
caus
virusinduc
immunolog
injuri
recent
studi
use
nhp
model
lasv
infect
demonstr
nhp
survivor
develop
patholog
find
consist
autoimmuneassoci
vascul
two
three
nhp
survivor
also
develop
sensorineur
hear
loss
similar
observ
human
case
histopatholog
examin
inner
ear
reveal
inflamm
vessel
perivascular
tissu
day
postinfect
long
acut
infect
subsid
furthermor
serolog
analysi
reveal
survivor
develop
elev
creactiv
protein
antineutrophil
cytoplasm
antibodi
indic
autoimmun
diseas
find
nhp
indic
hear
loss
acquir
lf
may
due
chronic
inflamm
studi
use
rodent
model
lasvinduc
hear
loss
provid
evid
hear
loss
may
caus
cellmedi
immun
respons
rather
direct
viral
damag
knockout
mice
infect
clinic
lasv
isol
develop
sensorineur
hear
loss
though
receptor
knockout
mice
interestingli
lasv
antigen
detect
inner
ear
type
mice
tissu
damag
observ
knockout
mice
concomit
profound
lymphocyt
infiltr
would
interest
determin
deplet
cell
could
prevent
hear
loss
model
one
studi
use
guinea
pig
model
lasv
infect
determin
anterior
uveiti
common
fatal
nonfat
lasv
infect
ocular
inflamm
larg
tcellmedi
howev
low
level
lasv
rna
detect
eye
guinea
pig
succumb
infect
well
survivor
viral
antigen
detect
eye
studi
immunohistochem
stain
reveal
persist
presenc
lasv
smooth
muscl
arteri
guinea
pig
nhp
model
infect
like
contribut
longlast
vascul
thu
current
hypothes
persist
low
level
lasv
replic
trigger
chronic
activ
adapt
cellular
immun
respons
lead
longlast
inflamm
arenavirus
repres
continu
emerg
threat
human
increasingli
come
contact
rodent
reservoir
data
clinic
anim
model
studi
demonstr
pathogen
ow
nw
arenavirus
elicit
vastli
differ
immun
respons
implic
viral
pathogenesi
lasv
infect
character
weak
delay
ifni
cytokin
induct
tcell
respons
pathogen
nw
arenavirus
junv
macv
trigger
robust
ifni
proinflammatori
cytokin
respons
though
mechan
behind
differ
remain
poorli
defin
sever
observ
note
junv
macv
infect
activ
varieti
prr
like
dsrna
accumul
lasv
seem
evad
prr
detect
arenavirus
test
far
arenavir
np
z
protein
capabl
interf
prr
activ
block
innat
immun
signal
express
studi
nevertheless
activ
viral
infect
remain
determin
differ
innat
immun
respons
like
account
differ
seen
adapt
respons
hemorrhag
fevercaus
arenavirus
overal
lasv
clearanc
associ
earli
strong
cellular
immun
respons
recent
find
implic
cellular
immun
respons
key
contributor
chronic
inflamm
sequela
seen
lf
survivor
profound
implic
lasv
vaccin
develop
particularli
lasv
vaccin
candid
base
tcell
respons
protect
recoveri
pathogen
nw
arenaviru
infect
mediat
humor
respons
howev
pathogen
nw
arenavirus
invad
immuneprivileg
central
nervou
system
may
evad
clearanc
potenti
caus
neurolog
sequela
knowledg
may
inform
develop
neutral
antibodybas
therapi
treat
ahf
bhf
patient
appreci
differenti
immun
respons
highli
pathogen
nw
ow
arenavirus
facilit
ration
design
target
therapeut
vaccin
